SAN CARLOS, Calif.--(BUSINESS WIRE)--NuGEN Technologies today launched a sample preparation product that allows NGS detection of multiple changes in more than 500 individual genes implicated in cancer.
The reagent kit, based on NuGEN’s Single Primer Enrichment Technology (SPET), is called the Ovation Cancer Panel 2.0 Target Enrichment System. The new kit updates NuGEN’s well-established Ovation Cancer Panel Target Enrichment System both by enriching for an improved and larger selection of cancer-related genes, and by enabling the detection of gene level copy-number variations (CNV) in addition to SNPs, mutations and indels, in a single workflow. It can be used with either fresh or FFPE tissue sections to deliver sensitive and reproducible targeted genomic analysis.
Help employers find you! Check out all the jobs and post your resume.
